NMDI14

Name: NMDI14
Brand: MedChemExpress
SKU: HY-111374
Rating: 5.0 (16 reviews)

Cat. No.: HY-111374 Purity: 99.68%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

NMDI14 is a nonsense mediated RNA decay (NMD) inhibitor. NMDI14 disrupts the SMG7-UPF1 interactions and inhibits NMD.

For research use only. We do not sell to patients.

CAS No. : 307519-88-6

Size	Stock	Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	In-stock	Estimated Time of Arrival: December 31
Solid
1 mg	In-stock	Estimated Time of Arrival: December 31
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	In-stock	Estimated Time of Arrival: December 31
25 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	In-stock	Estimated Time of Arrival: December 31
100 mg	In-stock	Estimated Time of Arrival: December 31
200 mg	Get quote
500 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 16 publication(s) in Google Scholar

16 Publications Citing Use of MCE NMDI14

RT-PCR

: NMDI14 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Jul 21;16(1):6695. [Abstract]; NMDI14 (50 μM; 6 h). RT-qPCR analysis revealing lncRNA GAS5 and UFD1s RNA levels in HEK293T cells under NMDI14 or TG treatments. GAS5 is a known NMD target, and was served as a positive control.

: NMDI14 purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Mar 17:e2414211. [Abstract]; NMDI14 (5-10 μM; 48 h). P53 expression in cells overexpressing circCANX or its control and treated with NMDI14 based on western blotting.

: NMDI14 purchased from MedChemExpress. Usage Cited in: Diabetologia. 2025 Jan;68(1):128-151. [Abstract]; NMDI14 (5 μM; 16 h). RT-qPCR of the four WFS1 isoforms in WFS1 iPSCs after treatment with NMDI-14 or vehicle.

: NMDI14 purchased from MedChemExpress. Usage Cited in: Nature. 2023 Jun;618(7966):842-848. [Abstract]; NMDI14 (NMD14; 5 µM; 12 h). CFTR mRNA level was normalized to that in untreated cells.

: NMDI14 purchased from MedChemExpress. Usage Cited in: Nature. 2023 Jun;618(7966):842-848. [Abstract]; NMDI14 (NMD14; 5 µM; 24 h). Representative immunoblots using monoclonal CFTR-NBD2 antibody in 16HBEge^R1162X/− transfected with sup-tRNA alone using lipofectamine or treated with NMD14.

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All DNA/RNA Synthesis Isoform Specific Products:

View All Isoforms

RNASE L DNA Polymerases RNA Polymerases Helicases DNA Ligase

Biological Activity
Protocol
Purity & Documentation
References
Customer Review

Description

NMDI14 is a nonsense mediated RNA decay (NMD) inhibitor. NMDI14 disrupts the SMG7-UPF1 interactions and inhibits NMD.

IC₅₀ & Target

NMD^[1]

In Vitro

NMDI14 is a nonsense mediated RNA decay (NMD) inhibitor. Treating cells with NMDI14 for 6 hours leads to an increase of PTC 39 β globin to 12%, a relative four-fold increase that, if resulting in biologically active hemoglobin, would be sufficient to ameliorate the clinical symptoms of thalassemia. Three days of treatment with NMDI14 results in no decrease in cell counts, demonstrating that the pharmacological inhibition of NMD can be achieved without subtle changes in proliferation. 941 genes are increased >1.5 fold with NMDI14. The treatment of N417 cells with NMDI14 for 6 hours leads to a steady state expression of p53 similar to that seen in U2OS cells. NMDI14 significantly increases the stability of PTC mutated p53 mRNA in N417 cells, without altering the stability of wild-type p53 in NMDI-treated U2OS cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

415.51

Formula

C₂₁H₂₅N₃O₄S

CAS No.

307519-88-6

Appearance

Solid

Color

Light yellow to yellow

SMILES

O=C(C1=C(NC(CC2NC3=C(C=C(C)C(C)=C3)NC2=O)=O)SC(C)=C1C)OCC

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : 10 mg/mL (24.07 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.4067 mL	12.0334 mL	24.0668 mL
5 mM	0.4813 mL	2.4067 mL	4.8134 mL
10 mM	0.2407 mL	1.2033 mL	2.4067 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

Purity & Documentation

Purity: 99.68%

Select Batch:

Data Sheet (276 KB) SDS (251 KB)

COA (250 KB) HNMR (312 KB) RP-HPLC (255 KB) LCMS (96 KB)

Handling Instructions (2659 KB)

References

[1]. Martin L, et al. Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutations. Cancer Res. 2014 Jun 1;74(11):3104-1 [Content Brief]

[2]. Aksit MA, Bowling AD, Evans TA, et al. Decreased mRNA and protein stability of W1282X limits response to modulator therapy. J Cyst Fibros. 2019;18(5):606-613. [Content Brief]

Cell Assay
^[1]

To assess viability cells are cultured in 6 well dishes and incubated with DMSO, G418, NMDI alone or G418 with NMDI together for the indicated hours. After incubations, cells and media are collected and cells viability is measured. To assess cell proliferation U2OS, Hela and BJ-htert cells are cultured in 6 well plates and, after 24 hrs, treated with NMDI14 for 0, 24, 48 and 72hrs. The cells are collected and viable cells are counted by using the Countess Automated Cell Counter^[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

References

[1]. Martin L, et al. Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutations. Cancer Res. 2014 Jun 1;74(11):3104-1 [Content Brief]

[2]. Aksit MA, Bowling AD, Evans TA, et al. Decreased mRNA and protein stability of W1282X limits response to modulator therapy. J Cyst Fibros. 2019;18(5):606-613. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.4067 mL	12.0334 mL	24.0668 mL	60.1670 mL
	5 mM	0.4813 mL	2.4067 mL	4.8134 mL	12.0334 mL
	10 mM	0.2407 mL	1.2033 mL	2.4067 mL	6.0167 mL
	15 mM	0.1604 mL	0.8022 mL	1.6045 mL	4.0111 mL
	20 mM	0.1203 mL	0.6017 mL	1.2033 mL	3.0084 mL

NMDI14 Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

NMDI14307519-88-6NMDI 14NMDI-14DNA/RNA SynthesisInhibitorinhibitorinhibit

Your Recently Viewed Products:

Product Name

Requested Quantity *

Applicant Name *

Salutation

Email Address *

Phone Number *

Department

Organization Name *

City

State

Country or Region *

Remarks

Product Name

Lot #

Applicant Name *

Email Address *

Phone Number

Department *

Organization Name *

Country or Region *

Remarks

Name
Email *

	Sorry, but the email address you supplied was invalid.

NMDI14

Customer Review

NMDI14 Related Antibodies

16 Publications Citing Use of MCE NMDI14

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All DNA/RNA Synthesis Isoform Specific Products:

Biological Activity

Protocol

Purity & Documentation

References

Customer Review

NMDI14 Related Antibodies

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

NMDI14 Related Classifications

Keywords:

Your Recently Viewed Products:

Customer Review

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report